The Effect of Individualized NUTritional Counselling on Muscle Mass and Treatment Outcome in Patients With Metastatic COLOrectal Cancer Undergoing Chemotherapy: the COLONUT Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stage IV Colorectal Cancer
- Sponsor
- Amsterdam UMC, location VUmc
- Enrollment
- 107
- Locations
- 5
- Primary Endpoint
- Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose is to study the effect of individualized nutritional counselling compared to usual nutritional care on cross-sectional muscle area in patients with stage IV colorectal cancer during first line chemotherapy. Secondary, effect on total lean body mass, treatment intensity, physical functioning, quality of life and survival will be studied.We hypothesize that patients in the intervention arm benefit from individualized nutritional counseling.
Investigators
M.A.E van Bokhorst - de van der Schueren, Dr.
Senior Investigator dietetics and nutrition sciences Vumc
Amsterdam UMC, location VUmc
Eligibility Criteria
Inclusion Criteria
- •Age ≥18 years
- •Stage IV colorectal cancer
- •Scheduled for treatment with first line chemotherapy, either CAPOX(-B), FOLFOX(-B) or capecitabine(-B)
- •CT scan suitable for evaluating muscle mass at L3 level
- •Understanding of the Dutch language
- •Able and willing to give written informed consent
Exclusion Criteria
- •Chemotherapy in the previous three months
- •WHO performance status ≥ 3
- •Long-term high dose of corticosteroids: ≥ three weeks ≥ ten milligram prednisolon or equivalent
Outcomes
Primary Outcomes
Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
Time Frame: During 9 weeks of first line chemotherapy
will be measured with SliceOmatic software V5.0 (Tomovision) with use of routinely conducted CT scans for diagnostic and disease evaluation purposes
Secondary Outcomes
- Change in total body lean body mass and segmental lean body mass (DEXA) in patients with stage IV colorectal cancer during 9 weeks of first line chemotherapy between individualized nutritional counseling versus usual nutritional care(During 9 weeks of first line chemotherapy)
- Change in skeletal muscle area in patients with stage IV colorectal cancer during 20 weeks of first line chemotherapy between individualized nutritional counseling.versus usual nutritional care.(During 20 weeks of first line chemotherapy)
- Associations of (changes in) muscle area with (changes in) mid-upper arm muscle circumference, whole body fat free mass (BIA) and whole body lean body mass (DEXA).(During 9 weeks of first line chemotherapy)
- Composite of treatment toxicity, treatment intensity, treatment outcome, survival, physical functioning, quality of life and hand grip strength of both study arms(During 9 weeks and during 20 weeks of first line chemotherapy)